In one paragraphReview in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Xiaona SongDivision of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
Xiaoqiong TangCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.
Alfred TayHelicobacter pylori Research Laboratory, Marshall Centre for Infectious Disease Research and Training, School of Biomedical Sciences, University of Western Australia, Nedlands, WA 6009, Australia.ORCID 0000-0001-9705-4010 Mohammed BenghezalCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0000-0002-4207-0192 Barry J MarshallHelicobacter pylori Research Laboratory, Marshall Centre for Infectious Disease Research and Training, School of Biomedical Sciences, University of Western Australia, Nedlands, WA 6009, Australia.ORCID 0000-0003-4853-5015 Hong TangDivision of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China.
Hong LiCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.
Funding
National Natural Science Foundation of China Grant No.82300649 and 32470189the International Cooperation Excellence Initiative Grant from West China Hospital, Sichuan University Grant No. 139220012
6 · The paper itselfAbstract
VacA (vacuolating cytotoxin A) is a key virulence factor in
Indexed as
Bacterial ProteinsHelicobacter InfectionsHelicobacter pyloriPolymorphism, GeneticAnimalsHumansVirulence FactorsBacterial ProteinsVacA protein, Helicobacter pyloriVirulence Factorsbiological functiongenotypeHelicobacter pylori infectionoligomerizationvacuolating toxin A
Identifiers
PMID42509860
PMCPMC13406591
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390